Exchange: NASDAQ·Updated 07:30 PM EDT

KLRA Kailera Therapeutics Inc.

$11.25
$0.46
(3.93%)
Today
Closed $11.25
$0.00
(0.00%)
After Hours
EarningsNov 4
Mkt Cap$1.46B
Vol1.3M

About KLRA

Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide. The company was founded on May 08, 2024 and is headquartered in Waltham, MA.
35

Bearish Sentiment

How do you feel about KLRA?

Gergely_Blasko
Did you realize that Kailera ( $KLRA ) acquired the commercial rights to the compound at the center of its research from this very same Chinese company (Jiangsu Hengrui Pharmaceuticals)? $NVO also has to think about the future. A 100-year-old company doesn’t think in 1–2–3-year timeframes. If it did, that would be a very serious problem. And besides, as a first-generation dual agonist, there’s always oral CagriSema in the pipeline.
1
stockydennis
$KLRA trading volume heavy over 800k at noon on a Friday, long wkd ahead, loaded over 12k shares.
2
BluntForceOptions
$KLRA Setup is materializing cleanly here (1-hour) We have higher lows printing off that $11.80 ish bottom shelf. A clean, decisive push above this compression zone clears the 50 SMA and opens the door for a quick run toward the 100 SMA (around $14.05), with that primary $16.50+ horizontal target in view. Range is tight, indicators are turning up, and if this clears, we’re off to the races. Stay tuned.
1
BluntForceOptions
Sized up heavy on $KLRA today. Flashed a 9 handle briefly before putting in a steady base in the mid-$10 s. Stepped in with conviction and backed up the truck... accumulating straight common for the ride. FYI: options are officially trading on the tape now for those interested. Giddy up.
DG20
$KLRA Cagrisema is GLP/Amylin and these are not interchangeable with GLP/GIP. Amylin dual agonists increase side effects whereas GIP dual agonists decrease side effects. Cagrisema is an inferior drug to Tirzepatide (WL, side effects, A1C)… KLRA chose the correct MOA

Advertisement|Remove ads.